PMID- 26803356 OWN - NLM STAT- MEDLINE DCOM- 20161110 LR - 20181202 IS - 1872-8227 (Electronic) IS - 0168-8227 (Linking) VI - 113 DP - 2016 Mar TI - Lispro insulin in people with non-alcoholic liver cirrhosis and type 2 diabetes mellitus. PG - 179-86 LID - S0168-8227(16)00009-7 [pii] LID - 10.1016/j.diabres.2015.12.006 [doi] AB - AIMS: To compare metabolic control under lispro and recombinant regular human insulin (RHI) in people with diet-unresponsive type 2 diabetes mellitus (T2DM) and compensated non-alcoholic liver disease (CLD). METHODS: 108 people with T2DM and CLD were randomly allocated to RHI or lispro according to a 12+12 week cross-over protocol. A 1-week continuous glucose monitoring (CGM) session was performed at the end of each treatment period followed by a standard meal test with a 12IU lispro or RHI shot ahead. RESULTS: CGM showed higher glycemic excursions under RHI than under lispro (p<0.01) with lower glucose levels in the late post-absorption phase (p<0.05) and even more during the night (p<0.01). Post-challenge incremental areas under the curve (DeltaAUC) were undistinguishable for insulin but lower for glucose, while insulin peaked higher and earlier and glycemic excursions were lower with lispro than with RHI (0.05